Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ANDA Exclusivity Protected From Patent Delisting Under Appeals Court Ruling

Executive Summary

Generic companies will no longer lose 180-day marketing exclusivity solely because a brand name company delists a patent they have challenged

You may also be interested in...

FDA Hit With Slew Of Suits As Firms Fight For Market Advantage

At least nine complaints have been filed against the agency since March, most involving market exclusivity claims; lawyers expect innovators will be pursuing more cases as patents expire and biosimilars emerge.

Caraco Seeks Supreme Court Intervention In Its Prandin Patent Use Code Battle With Novo

Caraco asks the Supreme Court to decide whether it can file a counterclaim opposing Novo's revision of its patent use code for the diabetes drug.

FDA Wrangles With Generic Exclusivity, Looks To Courts For Direction

For FDA, resolving 180-day exclusivity issues may be as difficult as Lisbeth Salander’s quest to figure out Fermat’s Last Theorem.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts